Table 2.
Description of Clozapine (n = 1004) and Olanzapine (n = 2256) and Samples by Non-Time Changing Characteristics, Based on Prescription Registers for the Whole of Sweden, Reflecting First Withdrawal of Each Drug Between January 1, 2006 to December 31, 2010
| Clozapine | Olanzapine | |
|---|---|---|
| Count (%) | Count (%) | |
| Year of treatment start | ||
| 2006 | 204 (20.32) | 664 (29.41) |
| 2007 | 194 (19.32) | 490 (21.7) |
| 2008 | 201 (20.02) | 360 (15.94) |
| 2009 | 213 (21.22) | 372 (16.47) |
| 2010 | 192 (19.12) | 372 (16.47) |
| Gender | ||
| Male | 663 (66.04) | 1385 (61.34) |
| Female | 341 (33.96) | 873 (38.66) |
| Born in Sweden | 797 (79.38) | 1721 (76.22) |
| Duration of treatment | ||
| 8 weeks–1 year | 224 (22.31) | 1001 (44.33) |
| 1–3 years | 446 (44.42) | 788 (34.90) |
| 3 years or more | 334 (33.27) | 469 (20.77) |
| Educational attainment at treatment start | ||
| ≤9 years | 343 (34.16) | 702 (31.09) |
| 10–12 years | 576 (57.37) | 1317 (58.33) |
| University or higher | 53 (5.28) | 172 (7.62) |
| Missing | 32 (3.19) | 67 (2.97) |
| Age at drug start (years) | ||
| 18 < 28 | 206 (20.52) | 295 (13.06) |
| 28 < 38 | 331 (32.97) | 578 (25.6) |
| 38 < 48 | 319 (31.77) | 920 (40.74) |
| 48 < 58 | 148 (14.74) | 465 (20.59) |
| Start periods | ||
| Before 2007 | 398 (39.64) | 1154 (51.11) |
| After 2008 | 606 (60.36) | 1104 (48.89) |
| Period of psychotic disorders diagnosis | ||
| 1970–1982 | 34 (3.39) | 102 (4.52) |
| 1983–1991 | 137 (13.65) | 295 (13.06) |
| 1992–2001 | 291 (28.98) | 585 (25.91) |
| 2002– | 542 (53.98) | 1276 (56.51) |
| Age at psychotic disorders diagnosis | ||
| 18 < 28 | 536 (53.39) | 861 (38.13) |
| 28 < 38 | 310 (30.88) | 763 (33.79) |
| 38 < 48 | 141 (14.04) | 527 (23.34) |
| 48 < 58 | 17 (1.69) | 107 (4.74) |